Last reviewed · How we verify
NCT05704569
Prediction of Primary Cardiovascular Events Using the Multimarker Approach
trial testing measurement of multiple biomarkers in Cardiovascular Diseases in 1,500 participants. Completed in 1 December 2022.
1 March 2020
Quick facts
| Lead sponsor | Karaganda Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 1 June 2014 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 December 2022 |
Drugs / interventions tested
- measurement of multiple biomarkers
Conditions studied
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Stroke — all drugs for Stroke →
- Myocardial Infarction — all drugs for Myocardial Infarction →
- Death — all drugs for Death →
Sponsor
Karaganda Medical University
Who can join
Adults 25 to 65, any sex, with Cardiovascular Diseases or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study of biochemical risk factors for cardiovascular diseases is important not only for analysis, but also for preventive measures, given that changes in the level of biomarkers can be detected before the first clinical manifestations of CVD. Accordingly, patients at high CV risk may have additional motivation to lead a healthy lifestyle. In addition, information on biochemical risk markers can be used to optimize the clinical management of patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05704569
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
- NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Karaganda Medical University trials
Trials by the same sponsor.
- NCT07294911 — Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome · completed
- NCT06460753 — Analysis of Laboratory Markers for Severe COVID-19 · completed
- NCT06937346 — Rehabilitation Robotic System ReHand · NA · completed
- NCT06221293 — Correlation Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage · active not recruiting
- NCT05222893 — Optimization of PEEP During Laparoscopic Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05704569 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karaganda Medical University
- Last refreshed: 15 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05704569.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing